Canada is another step closer to producing home-grown vaccines.
Construction is complete at the Biologics Manufacturing Centre in Montreal, which will be able to produce about 24-million COVID-19 vaccine doses a year.
The National Research Council of Canada is working with Novavax to produce a vaccine there.
Equipment is still being installed and the site is not yet fully licensed and operational.
Federal Innovation Minister Francois-Philippe Champagne made the announcement today regarding the Biologics Manufacturing Centre, which is located on the National Research Council of Canada's Royalmount site.